Stay updated on TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision (v3.4.2) was added with an updated Study Status, and the previous revision (v3.4.1) was removed from the history.SummaryDifference0.4%

- Check27 days agoChange DetectedThe history shows a minor revision update from v3.4.0 to v3.4.1 in the revision history; no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedUI changes include a glossary display and color-coding explanations in the history view. Sponsor entries were updated, with AbbVie added and TeneoOne Inc. removed in the history records.SummaryDifference2%

- Check49 days agoChange DetectedThe revision history now shows a new Revision: v3.3.4 and the removal of Revision: v3.3.3, updating metadata rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.3.3 was added to the page history. The footer now no longer shows 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check98 days agoChange DetectedA new revision entry (v3.3.2) has been added, replacing the previous v3.2.0, with no changes to study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNB-383B Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.